```
Sign in Subscribe
By Ainvest in options-flow —

🔥 UPST $6.7M Multi-Leg Position Ahead of Earnings - Sophisticated Play on AI Comeback!

Whale trade detected: $6.7M institutional position on UPST. Someone just deployed $6.7 MILLION across three simultaneous options trades on Upstart...

🎯 The Quick Take

Someone just deployed $6.7 MILLION across three simultaneous options trades on Upstart at 11:24:28 AM today! This massive 8,498-contract structure combines Nov 7th calls and puts with Oct 31st downside protection - all expiring around Q3 earnings on November 4th. With UPST down 6% to $46.78 today and trading 26% below its year-start price, smart money is making a sophisticated bet on the AI lending platform's earnings catalyst just 5 days away. Translation: Institutional player positioning for major volatility around Q3 results!

📊 Company Overview

Upstart Holdings (UPST) is an AI-powered lending marketplace revolutionizing credit underwriting:
- Market Cap: $4.69 Billion
- Industry: Finance Services
- Current Price: $46.78 (down $2.92 or -6.0% today)
- Primary Business: AI platform connecting consumers to 100+ banks and credit unions, using proprietary models evaluating 2,500+ variables to achieve 92% fully automated loan approvals

💰 The Option Flow Breakdown

The Tape (October 30, 2025 @ 11:24:28):

Time Symbol Side Buy/Sell Type Expiration Premium Strike Volume OI Size Spot Option Price
11:24:28 UPST MID BUY CALL 2025-11-07 $2.9M $49.5 8.5K 83 8,498 $46.78 $3.44
11:24:28 UPST MID SELL PUT 2025-11-07 $2.3M $43 8.6K 269 8,498 $46.78 $2.76
11:24:28 UPST MID BUY PUT 2025-10-31 $1.5M $48 8.7K 18K 8,498 $46.78 $1.73

🤓 What This Actually Means

This is a synthetic long position with earnings protection - extremely sophisticated institutional play! Here's the breakdown:

Leg 1: BUY $49.5 CALLS (Nov 7 - after earnings)
- 💸 Premium paid: $2.9M ($3.44 per contract × 8,498 contracts)
- 🎯 Bullish bet: Positioning for rally above $49.50 post-earnings
- ⏰ Expires: 3 days AFTER Q3 earnings (Nov 4)
- 📊 Low open interest (83): This trade IS the market at this strike

Leg 2: SELL $43 PUTS (Nov 7 - after earnings)
- 💰 Premium collected: $2.3M ($2.76 per contract × 8,498 contracts)
- 🛡️ Willing to own: At $43 if stock drops (8.1% below current price)
- 📈 Creates leverage: Synthetic long exposure without buying stock
- 💡 Risk defined: Between $43-$49.5 breakeven zone

Leg 3: BUY $48 PUTS (Oct 31 - BEFORE earnings)
- 🚨 Near-term insurance: $1.5M ($1.73 per contract × 8,498 contracts)
- ⏰ Expires: This Friday (1 day BEFORE earnings announcement)
- 🛡️ Protection: Against pre-earnings selloff or leak
- 📊 Higher OI (18K): More liquid, easier exit if needed

Net Position Analysis:
- 💵 Net premium: -$2.1M spent ($2.9M + $1.5M paid, $2.3M collected)
- 🎯 Breakeven: ~$51 on upside (strike + net premium / contracts)
- 📊 Max risk: Limited to premiums paid if stock crashes below $43
- 🎲 Position notional: Represents ~850,000 shares worth $39.8M exposure
- 🏦 Execution quality: All three legs hit MID price simultaneously = institutional desk

What's really happening here:
This trader is betting on Q3 earnings beating expectations (November 4th after close) and is willing to risk $2.1M that UPST rallies above $49.50 within 3 days post-announcement. The Oct 31st put protects against any pre-earnings disasters, while the sold $43 put finances part of the structure and defines maximum downside.

Unusual Score: 🔥 EXTREME (1,155x average premium size) - This happens maybe once a year! The largest UPST options trade we've seen, representing a large fund-level allocation.

📈 Technical Setup / Chart Check-Up

YTD Performance Chart

UPST YTD Performance

Upstart is down -26.1% YTD with current price of $44.95. The chart tells a volatile recovery story - after rallying to $80+ in mid-summer following strong Q2 results, UPST has crashed 34% over the past three months on credit quality concerns.

Key observations:
- 📉 Brutal drawdown: -60.8% max drawdown from January highs near $61
- 🎢 Extreme volatility: 85.4% annualized volatility - this is NOT a sleepy stock
- 💔 Recent selloff: Down from $80 peak in July to current $45 levels
- 📊 Post-earnings pattern: Surged after Q2 beat in August, then gave back all gains on credit worries
- ⚠️ Critical support: Trading near YTD lows, needs earnings catalyst to reverse

Gamma-Based Support & Resistance Analysis

UPST Gamma Support/Resistance

Current Price: $44.91

The gamma exposure map shows UPST trapped between critical levels heading into earnings:

🔵 Support Levels (Put Gamma Below Price):
- $45 - Strongest nearby support with 14.3B total gamma (massive wall!)
- $43 - Major secondary support at 4.8B gamma (matches SOLD PUT strike!)
- $42.5 - Put support zone with 0.82B gamma
- $40 - Deep support with 0.98B gamma

🟠 Resistance Levels (Call Gamma Above Price):
- $47-$48 - Immediate resistance zone with 7.1-7.8B gamma
- $50 - Major ceiling with 3.1B gamma exposure
- $52-52.5 - Extended resistance at 0.66-0.82B gamma
- $55 - Upper limit with minimal gamma beyond

What this means for traders:
The $45 level is absolutely LOADED with put gamma (13.9B) - market makers will aggressively buy any dips to hedge their positions, creating a strong floor. The trade structure makes perfect sense: sold puts at $43 (just below major support) and bought calls at $49.5 (between resistance levels). This suggests the trader expects earnings to break UPST out of the $45-$48 range.

Net GEX Bias: Bearish (15.2B call gamma vs 36.9B put gamma) - Heavy put positioning reflects market skepticism, but also means potential short squeeze if earnings surprise positive.

Implied Move Analysis

UPST Chart

Options market pricing for upcoming expirations:

  • 📅 Weekly (Oct 31 - 1 day): ±$1.55 (±3.44%) → Range: $43.39 - $46.49
  • 📅 Monthly OPEX (Nov 21 - 22 days): ±$8.82 (±19.62%) → Range: $36.12 - $53.76
  • 📅 Quarterly Triple Witch (Dec 19 - 50 days): ±$10.86 (±24.16%) → Range: $34.08 - $55.80
  • 📅 Yearly LEAPS (Sep 18, 2026 - 323 days): ±$23.93 (±53.24%) → Range: $21.01 - $68.87

Translation for regular folks:
Options traders are pricing in a MASSIVE 19.6% move ($8.82) through November expiration - that's huge for a $4.7B market cap stock! The market expects UPST to trade between $36-$54 over the next three weeks, with earnings as the primary catalyst.

The call buyer at $49.5 is betting on the upper end of this range ($53.76), while the put seller at $43 is comfortable owning stock at the lower support zone. This is a textbook volatility play heading into a binary earnings event.

🎪 Catalysts

🔥 Immediate Catalysts (Next 7 Days)

Q3 2025 Earnings - November 4, 2025 (5 DAYS AWAY!) 📊

Upstart will report fiscal Q3 2025 results after market close on Tuesday, November 4, 2025 at 4:30 PM ET. This is THE catalyst for the options positioning. Wall Street consensus:

What to watch:
- Credit quality metrics: After BTIG's incorrect 11.2% delinquency report (actually 6.2%) spooked markets, investors need reassurance
- AI Model 22 impact: 17 percentage point improvement in accuracy should drive better conversion rates
- Product diversification: Auto lending up 87% sequentially, HELOCs up 67% - now >10% of originations
- Full-year guidance: Current forecast is $1.05B revenue, $35M net income
- Partnership momentum: Recent additions of Peak Credit Union, CAFCU, and Pathward Bank

Historic context: UPST has shown extreme post-earnings volatility - stock dropped -18.7% after Q2 results despite beating estimates. At 85.4% annualized volatility, expect significant moves either direction.

🚀 Near-Term Catalysts (Q4 2025 - Q1 2026)

Banking & Credit Union Partnership Expansion 🏦

Recent partnerships demonstrating strong network growth:

These partnerships provide stable funding sources and expand origination capabilities - critical after past funding volatility concerns.

Product Diversification Momentum 📱

Beyond core personal loans (94% of Q2 volume), new products gaining traction:

🤖 AI & Technology Catalysts (2026)

Model 22 - Latest AI Breakthrough Scaling 🧠

Upstart's proprietary AI achieved 17 percentage point improvement in separation accuracy versus traditional credit models:

Operating Leverage Expansion 💰

Strong unit economics showing scalability:
- 58% contribution margin in Q2
- 20% adjusted EBITDA margin ($53M)
- Return to GAAP profitability a quarter ahead of schedule

💵 Funding & Capital Markets Catalysts (Ongoing)

Securitization Program Momentum 📑

Recent asset-backed securities providing diversified funding:

Provides capital markets funding alternative to bank partnerships, reducing concentration risk.

Federal Reserve Rate Environment 📉

With Fed cutting rates (first cut September 2025), lending conditions improving:
- Lower rates = more attractive borrowing costs for consumers
- Improved funding economics for lending partners
- Potential credit quality stabilization as rates decline

⚠️ Risk Catalysts (Negative)

Credit Quality Volatility 📊

Recent concerns creating headwinds:

High Short Interest - Double-Edged Sword ⚔️

Significant bearish positioning but also squeeze potential:

Stock Volatility & Valuation Risk 📈📉

Historical performance shows extreme swings:

Balance Sheet & Funding Concerns 💰

Capital structure adding risk:

  • 📊 $600M convertible debt issued
  • 📝 On-balance-sheet loans for new product R&D
  • ⚠️ Market hypersensitive to funding durability after past issues

Competitive Landscape Pressure 🥊

Facing established and emerging competition:

  • 🏦 Traditional banks with existing customer relationships
  • 💻 LendingClub, Affirm, SoFi and other fintechs with mature platforms
  • ❓ Need to prove AI model superiority through full economic cycles
  • 📊 Market share battles in auto and HELOC spaces intensifying

🎲 Price Targets & Probabilities

Using gamma levels, implied move data, and November 4th earnings catalyst, here are the scenarios:

📈 Bull Case (35% probability)

Target: $52-$58

How we get there:
- 💪 Q3 earnings beat expectations ($0.42 EPS, $280M revenue)
- 🎯 Loan originations accelerate beyond $2.8B Q2 levels on Model 22 improvements
- 📊 Credit quality metrics stabilize, delinquencies remain at healthy 6.2% levels
- 🚗 Auto lending and HELOC growth continues (87% and 67% sequential growth rates)
- 🏦 New bank partnerships (Pathward, Peak CU, CAFCU) drive origination volume beat
- 💰 GAAP profitability sustained, full-year guidance raised above $1.05B revenue
- 🔥 Short squeeze trigger: 35.7% short interest forces covering on positive surprise
- 📈 Breaks through $50 gamma resistance on momentum, targets $52-$55 zone

Gamma dynamics: Breaking $48 resistance and $50 ceiling would trigger dealer hedging flows that accelerate upside. Implied move upper range of $53.76 (Nov 21) aligns with this target.

Key metric to watch: Conversion rate (was 23.9% in Q2 vs 15.2% prior year) - if this hits 25%+, stock rips higher.

🎯 Base Case (45% probability)

Target: $42-$48 range

Most likely scenario:
- ✅ Solid earnings meeting consensus expectations (no major beat or miss)
- 📱 Q3 results confirm Q2 trends: growth continuing but at expected pace
- ⚖️ Credit quality stable but concerns linger about cycle sustainability
- 🏦 Partnership announcements positive but already telegraphed to market
- 💼 Profitability maintained but margins don't expand meaningfully
- 📊 Full-year guidance reiterated at ~$1.05B, no major revision
- 🔄 Trading within strong gamma support ($43-$45) and resistance ($47-$48) bands
- 😐 Market remains skeptical due to 85% volatility and credit cycle risks
- 💤 Stock consolidates, waits for next catalyst (Q4 earnings February 2026)

This matches the trade structure: Sold puts at $43 provide downside protection at major support, while bought calls at $49.5 expire worthless if stock stays range-bound. The Oct 31st put insurance expires before earnings, suggesting trader expects pre-earnings stability.

📉 Bear Case (20% probability)

Target: $38-$42

What could go wrong:
- 😰 Earnings miss or weak guidance disappoints bulls
- 💔 Credit quality deteriorates - delinquencies rise above 6.2% levels
- 📉 Loan originations disappoint as macro conditions weaken
- 🏦 Major funding partner pulls back or reduces volume
- 💰 Operating expenses rise faster than revenue, margins compress
- 🔴 GAAP profitability proves unsustainable, returns to losses
- 😱 Management commentary sounds cautious about 2026 outlook
- 📊 Auto and HELOC growth slows from Q2's 87%/67% sequential pace
- 🎢 Broader fintech selloff drags all lending stocks lower
- 🛡️ Key support: Strong put gamma at $43-$45 should limit downside unless fundamentals truly deteriorate

Important for the trade: Even in bear case, if UPST stays above $43, the sold puts expire worthless and trader only loses premium on the $49.5 calls ($2.9M) and $48 puts ($1.5M). Below $43, assignment risk kicks in but that's 8% below current price at major support.

💡 Trading Ideas

🛡️ Conservative: Wait for Post-Earnings Clarity

Play: Stay on sidelines until after November 4th earnings volatility settles

Why this works:
- ⏰ Earnings in 5 days creates massive binary event risk - too unpredictable
- 💸 Implied volatility at extreme levels (19.6% monthly move priced in) - options very expensive
- 📊 Stock down 34% in 3 months with 85% annualized vol - catching falling knives is dangerous
- 🎯 Better entry likely post-earnings after IV crush reduces option premiums 50-70%
- 📉 Historical pattern: UPST dropped 18.7% AFTER beating Q2 estimates - results don't guarantee direction
- ⚠️ With $600M convertible debt and balance sheet loans, any funding concerns could crater stock

Action plan:
- 👀 Watch Tuesday Nov 4th earnings closely for credit quality, loan origination trends, profitability sustainability
- 🎯 Look for pullback to $42-$43 gamma support for stock entry if fundamentals solid
- ✅ Confirm Model 22 driving conversion improvements and new products (auto/HELOC) scaling
- 📊 Monitor analyst reactions - upgrades would signal confidence shift
- 💚 If stock holds $43-$45 support post-earnings with positive report, consider December calls

Risk level: Minimal (cash position) | Skill level: Beginner-friendly

⚖️ Balanced: Post-Earnings Bull Put Spread

Play: After earnings settles, sell bull put spread if results positive

Structure: Sell $43 puts, Buy $40 puts (Dec 19 expiration)

Why this works:
- 🎢 IV crush after earnings makes spreads more favorable - sell elevated premiums
- 📊 Defined risk ($3 wide = $300 max risk per spread)
- 🛡️ Sold strike at $43 matches major gamma support level AND the institutional trade's put strike
- 💰 Collect premium betting stock holds above major support zone
- ⏰ 45 days to expiration gives time for positive sentiment to build if results good
- 📈 If UPST confirms profitability and credit quality stable, $43 should hold

Entry conditions (MUST wait for these):
1. ✅ Earnings results show beat or meet on EPS and revenue
2. ✅ Credit quality metrics stable or improving (delinquencies <7%)
3. ✅ Stock holds above $44-45 in first 24 hours post-earnings
4. ✅ IV rank drops from current elevated levels

Estimated P&L (adjust after seeing post-earnings pricing):
- 💰 Collect ~$0.80-1.20 credit per spread
- 📈 Max profit: $80-120 if UPST at/above $43 at December expiration (60-80% return on risk)
- 📉 Max loss: $180-220 if UPST below $40 (defined and limited)
- 🎯 Breakeven: ~$42-42.20 (below major support)
- 📊 Probability of profit: ~65-70% if earnings positive

Entry timing: Wait 1-2 days post-earnings for IV to fully collapse and price to stabilize

Risk level: Moderate (defined risk) | Skill level: Intermediate

🚀 Aggressive: Replicate the Whale Trade (HIGH RISK - ADVANCED ONLY!)

Play: Copy the institutional structure with smaller size

Structure:
- Buy $49.5 calls (Nov 7)
- Sell $43 puts (Nov 7)
- Buy $48 puts (Oct 31) for pre-earnings protection

Why this could work:
- 📊 Following institutional "smart money" that deployed $6.7M
- 🎯 Positioned for post-earnings rally above $49.50 if results beat
- 🛡️ Downside defined at $43 (major gamma support)
- ⏰ Oct 31 puts protect against pre-earnings leak or selloff
- 📈 Synthetic long exposure without capital to buy 100 shares per contract ($4,678 per 100 shares)
- 🔥 If short squeeze triggers on earnings beat (35.7% short interest), position explodes higher
- 💡 Net debit ~$2.50-3.00 per contract bundle for similar structure

Why this could blow up (SERIOUS RISKS):
- 💥 Earnings binary risk: Stock could gap down 15-20% on disappointment (historical precedent: -18.7% on Q2 BEAT)
- 😱 Already down 34% in 3 months - sentiment very negative, high bar to impress
- ⚠️ Credit quality landmine: Any deterioration in delinquencies tanks stock
- 📉 Funding concerns: If major bank partner reduces volume, massive selloff
- 💔 Stock has 85% volatility - normal -10% moves would breach $43 put strike
- 🚨 Assignment risk: Could be forced to buy 100 shares per contract at $43 ($4,300 per contract)
- ⏰ Time decay accelerates: Nov 7 expiry gives only 8 days total, theta burning $50-80/day per contract
- 💸 Margin requirements: Broker requires substantial capital for short puts (likely $2,000-3,000 per spread)

Estimated P&L per 1-contract bundle:
- 💰 Cost: ~$250-300 net debit ($344 call + $173 put - $276 put credit)
- 📈 Max profit: Unlimited above $52 (breakeven ~$52 = $49.5 strike + $2.50 net debit)
- 📉 Max loss: ~$700-800 if stock below $43 (buy at $43, worth less + premium lost)
- ⚡ Breakeven: ~$51.50-52.00 (needs 10% rally from current $46.78)
- 🎲 Realistic target: If earnings beat drives to $55, profit = ~$250-300 per bundle (100% return)

Position sizing (CRITICAL):
- ⚠️ Risk only 1-2% of portfolio on this lottery ticket
- 🎯 If you have $50K account, trade 1-2 contract bundles max ($500-600 risk)
- 💀 DO NOT bet the farm - this is a high-risk, high-reward speculation

Risk level: EXTREME (binary earnings event) | Skill level: Advanced only

⚠️ WARNING: DO NOT attempt this trade unless you:
- Have experience trading through earnings events and understand gap risk
- Can handle assignment of 100 shares per contract at $43 ($4,300 capital required per contract)
- Have sufficient margin (broker may require $2,000-3,000 per contract spread)
- Can actively monitor Nov 4th earnings call and adjust if needed
- Understand you could lose 100% of premium invested if wrong
- Accept this is essentially betting on Q3 beating estimates AND stock rallying 10%+
- Won't panic sell the Oct 31 protection before earnings if stock dips

Alternative - Safer Version:
If this is too aggressive, consider just buying $50 calls (Nov 21 expiration) for $2-3 premium AFTER earnings if results positive. This gives you upside exposure with defined risk, no assignment worries, and more time (22 days vs 8 days).

⚠️ Risk Factors

Don't get caught by these potential landmines:

  • ⏰ Earnings binary event in 5 days: Results Tuesday Nov 4th after close create MASSIVE volatility risk. Stock could gap 15-25% either direction based on results AND guidance. Historical precedent: dropped 18.7% AFTER beating Q2 estimates - results don't guarantee direction.

  • 💔 Credit quality is the Achilles heel: After misinformation about 11.2% delinquency rate (actually 6.2%) caused panic, market hypersensitive to any deterioration. One bad data point on loan performance could trigger 20% selloff. Macro slowdown increases default risk across lending platforms.

  • 🎢 Extreme volatility kills option buyers: 85.4% annualized volatility means 4-5% daily swings are NORMAL. Stock down 34% in 3 months despite beating Q2 estimates and returning to profitability. Trying to time entries/exits is brutal. IV crush post-earnings could erase 50-70% of option value even if directionally correct.

  • 🩳 35.7% short interest = double-edged sword: 28.68M shares short creates squeeze potential on positive surprise but also means significant bearish conviction from smart money. Shorts won't cover easily - they'll fight rallies. Could amplify moves in EITHER direction.

  • 💰 Balance sheet concerns remain: $600M convertible debt outstanding plus on-balance-sheet loans for new products creates funding risk. If major bank partner (Pathward with $7B AUM) reduces volume or pulls out, stock craters. Market won't give benefit of doubt.

  • 📉 Down 84% from 2021 highs: Long-term bagholders underwater from $400+ levels creates overhead supply. Every rally faces sellers trying to reduce losses. Psychological resistance around prior breakout levels ($55-60) very strong.

  • 🏦 New products unproven through credit cycle: Auto lending and HELOCs growing fast (87% and 67% sequential growth) but no track record through recession. If default rates spike in these new verticals, AI model's superiority gets questioned. Concentration in personal loans (94% of volume) remains high.

  • 📊 Analyst skepticism despite upgrades: Price targets range from $16.50 to $108 - massive dispersion shows no consensus. Goldman Sachs maintains Sell rating at $54 even as others upgrade. Credibility deficit after 84% drawdown from highs.

  • 🎯 Institutional trade could be a hedge: Just because smart money deployed $6.7M doesn't mean it's a pure directional bet. Could be hedging an existing portfolio position, or part of complex multi-name strategy. Don't blindly follow - understand your own risk tolerance.

  • ⚖️ Funding partner concentration: While 100+ partners sounds diversified, Pathward Bank alone is ~$7B AUM. Loss of 1-2 major partners could cut originations 20-30% overnight. Partnership announcements don't guarantee long-term commitment.

  • 💸 Profitability still fragile: Returned to GAAP profitability in Q2 with just $5.6M net income on $257M revenue - that's 2% margin. One bad quarter could flip back to losses. Need to prove sustainable earnings power over multiple quarters before market gives credit.

  • 🥊 Competition intensifying: LendingClub, SoFi, Affirm, traditional banks all fighting for same borrowers. AI advantage needs to be proven through full economic cycle. If competitors' models perform similarly in downturn, UPST's moat questioned.

🎯 The Bottom Line

Real talk: Someone just deployed $6.7 MILLION on a sophisticated three-legged options structure betting that Upstart's Q3 earnings (November 4th) trigger a rally above $49.50 within 3 days. This isn't your neighbor Bob's Robinhood account - this is institutional capital making a calculated bet with defined risk at major support levels. They're risking $2.1M net to potentially make multiples if UPST breaks out post-earnings.

What this trade tells us:
- 🎯 Sophisticated player expects Q3 to beat expectations ($0.42 EPS, $280M revenue) with strong loan origination growth
- 💰 Willing to own stock at $43 (8% below current, at major gamma support) if wrong
- 🛡️ Protected downside with Oct 31 puts in case of pre-earnings leak or selloff
- 📊 Breakeven around $51-52 requires 10% rally from current $46.78 - bullish but not insane
- ⚖️ Structure suggests expecting credit quality to stabilize and Model 22 improvements to drive results

If you own UPST:
- ⏰ Hold through earnings ONLY if you can stomach 15-25% move either direction
- ✅ Set mental stop at $42 (below major $43 gamma support) to protect capital
- 📊 If earnings beat with strong credit quality and guidance raise, $52-58 becomes realistic
- 🎯 Consider trimming 30-50% before earnings to reduce binary risk, let house money ride
- 💚 If results positive but stock flat/down initially (like Q2), add on weakness - market often overreacts

If you're watching from sidelines:
- ⏰ Tuesday November 4th after 4:30 PM ET is the moment of truth - mark your calendar
- 🎯 Post-earnings pullback to $42-43 would be attractive entry IF fundamentals solid
- 📈 Looking for confirmation of credit quality stable <7% delinquencies, loan originations accelerating, profitability sustained
- 🔥 Watch for short squeeze signal - if stock gaps up 10%+ on heavy volume with 35% short interest, squeeze could drive to $55-60
- ⚠️ Current -26% YTD with -34% 3-month decline = damaged chart, needs MAJOR catalyst to reverse sentiment
- 💡 Better risk/reward waiting for clarity than catching falling knife into earnings

If you're bearish:
- 🎯 Wait for earnings bounce to initiate short positions - selling into strength post-results safer than front-running
- 📊 First meaningful support at $43 (gamma wall), major support at $40 (put gamma)
- ⚠️ Watch for credit quality deterioration or funding partner concerns - those are legitimate bearish catalysts
- 📉 Put spreads ($48/$43 or $43/$38) post-earnings offer defined risk way to play downside
- 🩳 With 35.7% already short, crowded trade - need clear fundamental deterioration to justify adding

Mark your calendar - Key dates:
- 📅 October 31 (Thursday) - Oct 31 puts expire, near-term protection expires
- 📅 November 4 (Tuesday) 4:30 PM ET - Q3 2025 earnings report (THE CATALYST!)
- 📅 November 5 (Wednesday) - Post-earnings price discovery and IV crush
- 📅 November 7 (Friday) - Call/put structure expires, position outcome determined
- 📅 November 21 - Monthly OPEX, 19.6% implied move range tested
- 📅 December 19 - Quarterly triple witch expiration
- 📅 February 2026 - Q4 2025 earnings (next major catalyst)

Final verdict: This institutional trade is a high-conviction bet on earnings beating and credit quality stabilizing, with carefully structured risk management. The $43 put sale at major gamma support, $49.5 call above resistance, and Oct 31 pre-earnings protection show sophisticated positioning. However, UPST's 85% volatility, 34% recent decline, and binary earnings risk make this EXTREMELY high-risk.

For most retail traders, waiting for post-earnings clarity is the prudent move. If you have the risk tolerance and experience for earnings plays, the structure is sound - but position size accordingly. This is a "risk 1-2% of portfolio for potential 3-5x return" type of trade, not a "bet the farm" opportunity.

The catalyst is real (Q3 earnings in 5 days), the potential is there (AI model improvements + new product traction + 35% short interest squeeze potential), but so are the risks (credit quality, funding, volatility, sentiment). Trade accordingly.

Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for educational purposes only and not financial advice. Past performance doesn't guarantee future results. The 1,155x unusual score reflects this specific trade's size relative to recent UPST history - it happens maybe once a year but does not imply the trade will be profitable or that you should follow it. Earnings create binary event risk with potential for 15-25% gaps either direction. UPST has 85% annualized volatility and has dropped 84% from all-time highs. Always do your own research and consider consulting a licensed financial advisor before trading. Maximum loss on structures with short puts includes potential assignment of 100 shares per contract.

About Upstart Holdings Inc.: Upstart is an AI-powered lending marketplace with a $4.69 billion market cap, providing credit services through a proprietary cloud-based artificial intelligence lending platform in the Finance Services industry.

Subscribe to AInvest Option Labs

Don’t miss out on the latest issues. Sign up now to get access to the library of members-only issues.
jamie@example.com
Subscribe